Concepedia

Danielle Wallace

DW

Statistics

Publications

1

Citations

13

H-Index

1

Active since

2023

Affiliations

CDG Therapeutics (United States)(Current)

Danielle Wallace is an author at CDG Therapeutics (United States) specializing in bruton tyrosine kinase, immunotherapy, and combination therapy.

ORCID

Publications per year

2023–2023

1

Publications

1

Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia

Brian T. Hill, Shuo Ma, Clive S. Zent et al. · Blood Advances · 2023 · 13 citations · Full text

, , +14

1–1 of 1